The University of Southampton
University of Southampton Institutional Repository

Characteristics and outcomes of patients with imaging-defined MASLD and histological steatosis grade S0

Characteristics and outcomes of patients with imaging-defined MASLD and histological steatosis grade S0
Characteristics and outcomes of patients with imaging-defined MASLD and histological steatosis grade S0
Introduction: metabolic dysfunction-associated steatotic liver disease (MASLD) is a prevalent chronic liver disease, and liver biopsy remains the gold standard for diagnosis. However, a subset of patients diagnosed with MASLD by imaging paradoxically exhibit steatosis grade S0 on liver biopsy, posing a diagnostic challenge. This study investigated the outcomes and causes of steatosis 0.

Methods: steatosis 0 was defined as imaging-detected MASLD with a biopsy-defined steatosis grade S0. We used global cohorts to evaluate outcomes, histologic progression by paired biopsies, and possible causes. The cause analysis included MRI-proton density fat fraction (MRI-PDFF) for fat distribution, pathologist consistency testing, and comparison of serial biopsy sections.

Results: in a follow-up cohort of 3,273 biopsy individuals from 16 centers, 123 (3.8%) exhibited steatosis 0. Of these, 29.3% of them had advanced fibrosis (burnt-out MASLD) and demonstrated a risk of liver-related events, whereas those without advanced fibrosis had no such events. In the paired-biopsy cohort of 1,865 patients, 74 (4.0%) individuals initially showed steatosis grade S0; among them, 93.2% retained no or mild steatosis on follow-up biopsy. MRI-PDFF assessments in 42 MASLD patients revealed heterogeneous hepatic fat distribution, with some segments showing steatosis grade S0 despite elevated average liver fat. Interpathologist variability and discrepancies across consecutive biopsy sections contributed to misclassification of steatosis grade.

Discussion: steatosis 0 represents a potential diagnostic gray zone in MASLD. It may be caused by burnt-out MASLD, uneven liver fat distribution, or variability in pathological assessment. Understanding the causes and implications of steatosis 0 is critical for diagnosis and management.
Metabolic dysfunction-associated steatotic liver disease, biopsy, burnt-out, steatosis
0002-9270
Liu, Wen-Yue
f51ab24f-1bd2-44b4-b1d3-3e1dd86c6a3e
Lian, Li-You
fe52a16a-9318-4ecc-82a8-e5b2fb6840c4
Kim, Seung Up
98695451-dcca-4a98-95ca-2342360503a3
Yip, Terry Cheuk-Fung
d51e7539-adcd-41df-93a8-70787b9a3302
Petta, Salvatore
531e5934-f725-4b12-b541-d2c5d763295c
Byrne, Chris
1370b997-cead-4229-83a7-53301ed2a43c
et al.
Liu, Wen-Yue
f51ab24f-1bd2-44b4-b1d3-3e1dd86c6a3e
Lian, Li-You
fe52a16a-9318-4ecc-82a8-e5b2fb6840c4
Kim, Seung Up
98695451-dcca-4a98-95ca-2342360503a3
Yip, Terry Cheuk-Fung
d51e7539-adcd-41df-93a8-70787b9a3302
Petta, Salvatore
531e5934-f725-4b12-b541-d2c5d763295c
Byrne, Chris
1370b997-cead-4229-83a7-53301ed2a43c

Liu, Wen-Yue, Lian, Li-You and Kim, Seung Up , et al. (2026) Characteristics and outcomes of patients with imaging-defined MASLD and histological steatosis grade S0. American Journal of Gastroenterology. (doi:10.14309/ajg.0000000000004116).

Record type: Article

Abstract

Introduction: metabolic dysfunction-associated steatotic liver disease (MASLD) is a prevalent chronic liver disease, and liver biopsy remains the gold standard for diagnosis. However, a subset of patients diagnosed with MASLD by imaging paradoxically exhibit steatosis grade S0 on liver biopsy, posing a diagnostic challenge. This study investigated the outcomes and causes of steatosis 0.

Methods: steatosis 0 was defined as imaging-detected MASLD with a biopsy-defined steatosis grade S0. We used global cohorts to evaluate outcomes, histologic progression by paired biopsies, and possible causes. The cause analysis included MRI-proton density fat fraction (MRI-PDFF) for fat distribution, pathologist consistency testing, and comparison of serial biopsy sections.

Results: in a follow-up cohort of 3,273 biopsy individuals from 16 centers, 123 (3.8%) exhibited steatosis 0. Of these, 29.3% of them had advanced fibrosis (burnt-out MASLD) and demonstrated a risk of liver-related events, whereas those without advanced fibrosis had no such events. In the paired-biopsy cohort of 1,865 patients, 74 (4.0%) individuals initially showed steatosis grade S0; among them, 93.2% retained no or mild steatosis on follow-up biopsy. MRI-PDFF assessments in 42 MASLD patients revealed heterogeneous hepatic fat distribution, with some segments showing steatosis grade S0 despite elevated average liver fat. Interpathologist variability and discrepancies across consecutive biopsy sections contributed to misclassification of steatosis grade.

Discussion: steatosis 0 represents a potential diagnostic gray zone in MASLD. It may be caused by burnt-out MASLD, uneven liver fat distribution, or variability in pathological assessment. Understanding the causes and implications of steatosis 0 is critical for diagnosis and management.

Text
Manuscript_clean - Accepted Manuscript
Restricted to Repository staff only until 13 June 2027.
Request a copy
Text
sTable 1 - Accepted Manuscript
Restricted to Repository staff only until 13 June 2027.
Request a copy
Text
sTable 2 - Accepted Manuscript
Restricted to Repository staff only until 13 June 2027.
Request a copy
Text
sTable 3 - Accepted Manuscript
Restricted to Repository staff only until 13 June 2027.
Request a copy
Text
Table 1 - Accepted Manuscript
Restricted to Repository staff only until 13 June 2027.
Request a copy
Text
Table 2 - Accepted Manuscript
Restricted to Repository staff only until 13 June 2027.
Request a copy
Image
sFigure 1 - Accepted Manuscript
Restricted to Repository staff only until 13 June 2027.
Request a copy
Image
Figure 1 - Accepted Manuscript
Restricted to Repository staff only until 13 June 2027.
Request a copy
Image
Figure 2 - Accepted Manuscript
Restricted to Repository staff only until 13 June 2027.
Request a copy
Image
Figure 3 - Accepted Manuscript
Restricted to Repository staff only until 13 June 2027.
Request a copy
Image
Figure 4 - Accepted Manuscript
Restricted to Repository staff only until 13 June 2027.
Request a copy
Image
Figure 5 - Accepted Manuscript
Restricted to Repository staff only until 13 June 2027.
Request a copy

Show all 12 downloads.

More information

Accepted/In Press date: 12 June 2026
e-pub ahead of print date: 14 July 2026
Keywords: Metabolic dysfunction-associated steatotic liver disease, biopsy, burnt-out, steatosis

Identifiers

Local EPrints ID: 513749
URI: https://eprints.soton.ac.uk/id/eprint/513749
ISSN: 0002-9270
PURE UUID: 0a98f625-4b79-4878-93f8-ea6a9fdb788a
ORCID for Chris Byrne: ORCID iD orcid.org/0000-0001-6322-7753

Catalogue record

Date deposited: 26 Aug 2026 16:33
Last modified: 13 Sep 2026 15:50

Export record

Altmetrics

Contributors

Author: Wen-Yue Liu
Author: Li-You Lian
Author: Seung Up Kim
Author: Terry Cheuk-Fung Yip
Author: Salvatore Petta
Author: Chris Byrne ORCID iD
Corporate Author: et al.

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of https://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×